THC — Tenet Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $9.24bn
- $26.92bn
- $20.55bn
- 87
- 86
- 100
- 100
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18,479 | 17,640 | 19,485 | 19,174 | 20,548 |
Cost of Revenue | |||||
Gross Profit | 15,422 | 14,658 | 16,157 | 15,901 | 16,958 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17,169 | 15,967 | 16,688 | 16,950 | 18,049 |
Operating Profit | 1,310 | 1,673 | 2,797 | 2,224 | 2,499 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 320 | 671 | 1,888 | 1,344 | 1,617 |
Provision for Income Taxes | |||||
Net Income After Taxes | 160 | 768 | 1,477 | 1,000 | 1,311 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -215 | 399 | 914 | 411 | 611 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -215 | 399 | 914 | 411 | 611 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.561 | 2.25 | 5.83 | 5.59 | 9.89 |